Vitamins in Aging, Health, and Longevity by Thomas, David R
Clinical Interventions in Aging 2006:1(1) 81–91
© 2006 Dove Medical Press Limited. All rights reserved
81
REVIEW
Abstract: Evidence of epidemiological associations of vitamins and disease states have been
found for nine vitamins. In observational studies, people with a high intake of antioxidant
vitamins by regular diet or as food supplements generally have a lower risk of major chronic
disease, such as myocardial infarction or stroke, than people who are low consumers of
antioxidant vitamins. Prospectively, folate appears to reduce the incidence of neural tube
defects. Vitamin D is associated with a decreased occurrence of fractures when taken with
calcium. Zinc, betacarotene, and vitamin E appear to slow the progression of macular
degeneration, but do not reduce the incidence. Vitamin E and lycopene may decrease the risk
of prostate cancer. In other randomized controlled trials, the apparent beneficial results of a
high intake of antioxidant vitamins seen in observational studies have not been confirmed.
There is increasing concern from these trials that pharmacological supplementation of vitamins
may be associated with a higher mortality risk.
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Introduction
Food is essential to survival and health. Our ability to expend energy depends on an
adequate intake of protein and calories. However, nutritional deficiency diseases can
occur even when adequate calories are available. Historically, physicians have
observed that a number of peculiar disease states such as scurvy, pellegra, and beriberi
were directly related to dietary intake. These diseases were also found in the presence
of adequate calorie and protein intake. These strange nutritional deficiency states
perplexed researchers until the turn of the century.
A brief history of vitamins
With the ability to synthesize organic compounds around the turn of the 19th century,
researchers believed that food could be produced in the laboratory as well as in
nature. An “adequate diet” could be manufactured by combining purified protein,
carbohydrates, and fats with inorganic salts and water. Experimental animals fed
purified organic compounds failed to thrive. In an early experiment in 1881, Lunin
found that young mice did not grow when fed an apparently adequate amount of
purified organic compounds. In 1905, Pickelharing found that substitution of small
amounts of milk in place of water allowed animals to survive on a purified organic
compound diet. He concluded that there was some “unknown substance” in the milk
without which the animals could not survive.
A peculiar polyneuritis, later identified with beriberi, developed in chickens fed
on a diet of polished rice. In 1884, Christine Eijkman demonstrated that this
polyneuritis could be prevented or cured in fowl by feeding them unpolished rice
instead of polished rice. Following the current vogue, Eijkman believed that a “germ”
was neutralized by “something” in the husks of unpolished rice. In 1911, Casimir
Funk proposed that the Eijkman factor was not a germ, but a pyrimidine compound.
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The pyrimidine compound cured beriberi when fed to
pigeons. Since the compound appeared to be “vital” to life,
and since he thought it was an amino acid, he named the
compound a “vitamine”. The name stuck, although the final
“e” was dropped when it was later shown that vitamins were
not amines. A vitamin was recognized as an organic
compound present in the diet necessary for normal metabolic
functioning.
Scurvy was known to be cured by lemons and limes by
1753, but was not recognized as a nutritional deficiency. A
guinea pig model of scurvy was developed in 1907, rapidly
leading to a demonstration that scurvy could be prevented
by addition of a “water-soluble factor C” to the diet. The
organic compound was isolated and named ascorbic acid in
1928. This finding of a minute amount of a substance
essential to health in the diet resulted in the award of the
1937 Nobel Prize in Chemistry to research with ascorbic
acid.
The ability of biochemists to produce a compound in
the laboratory identical to the “natural” substance led to the
availability of nutritional supplements aimed at preventing
disease. Widespread use of these compounds has had a
profound effect in worldwide prevention, such as vitamin
D supplementation of milk. These “vitamins” were essential
for normal metabolic functioning and the consumption of
an abundance of vitamins could possibly prevent disease.
Vitamins and aging
Theories of cellular and organism aging developed in the
middle twentieth century. One of the leading theories
proposed that damage to cellular mechanisms and tissues
occurs because of chronic damage resulting from oxidative
stress on the organism due to free oxygen radicals.
Endogenous oxidative damage to proteins, lipids, and DNA
is thought to be an important etiologic factor in aging and
the development of chronic diseases such as cancer,
atherosclerosis, and cataract formation. The harm associated
with these diseases is likely to occur only after the production
of reactive oxygen species exceeds the body’s or cell’s
capacity to protect itself and effectively repair oxidative
damage. There is a hypothesized effect, which relates
antioxidant vitamins and aging. Certain “antioxidant”
compounds might “scavenge” these damaging free oxygen
radicals and prevent cellular destruction and aging. Vitamin
C, vitamin E, and betacarotene, often referred to as
“antioxidant vitamins”, have been suggested to limit
oxidative damage in humans and lower the risk of certain
chronic diseases.
This hypothesis has driven a large number of epi-
demiological studies and clinical trials examining the
efficacy of antioxidant vitamins. The mechanism by which
certain vitamins may lower in vivo oxidative damage to
lipids, proteins, or DNA is not known. The current evidence
is insufficient to conclude that antioxidant vitamin
supplementation materially reduces oxidative damage in
humans (McCall and Frei 1999), with the exception of
supplemental vitamin E and possibly vitamin C being able
to significantly lower lipid oxidative damage in both smokers
and non-smokers.
Aging is associated with increased risk for low vitamin
consumption. In the United States, total energy intake
decreases substantially with age: by 1000 kcal–1200 kcal
in men, and by 600 kcal–800 kcal in women in the seventh
decade. This results in concomitant declines in most nutrient
intakes. Lower food intake among the elderly has been
associated with lower intakes of calcium, iron, zinc,
B vitamins, and vitamin E. This low energy intake or low
nutrient density of the diet may increase the risk of diet-
related illnesses. Fifty percent of older adults have a vitamin
and mineral intake less than the recommended daily intake
(RDI), while 10%–30% have subnormal levels of vitamins
and minerals (Wakimoto 2001). Populations at high risk
for inadequate vitamin intake include elderly people,
vegans, alcohol-dependent individuals, and patients with
malabsorption.
Older adults tend to consume less energy-dense sweets
and fast foods, and consume more energy-dilute grains,
vegetables, and fruits. Daily volume of foods and beverages
also declines as a function of age. Physiological changes
associated with age, including slower gastric emptying,
altered hormonal responses, decreased basal metabolic rate,
and altered taste and smell may also contribute to lowered
energy intake. Other factors such as marital status, income,
education, socioeconomic status, diet-related attitudes and
beliefs, and convenience likely play a role as well (Thomas
2002). Many age-related nutritional problems may be
remedied to an extent by providing nutrient-dense meals
through home delivery or meal congregate programs
(Drewnowski and Shultz 2001).
Antioxidant vitamins
The vitamin A and carotienoid family
The carotenoids are a diverse group of more than 600
naturally occurring pigments. Natural sources include
yellow, orange, and red plant compounds such as carrots
and green leafy vegetables. Humans cannot synthesizeClinical Interventions in Aging 2006:1(1) 83
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carotenoids and exclusively depend on dietary intake for
these micronutrients. Betacarotene and lycopene are the
major dietary carotenoids. Lycopene is a natural pigment
synthesized by plants and microorganisms but not by
animals. It occurs in the human diet predominantly in
tomatoes and processed tomato products. It is a potent
antioxidant and the most significant free radical scavenger
in the carotenoid family. There is no known deficiency state
for carotenoids themselves and no recommended daily
intake. Betacarotene can be converted to vitamin A, whereas
lycopene cannot. All of the carotenoids are antioxidants and
approximately 50 are considered vitamins because they
have provitamin A activity. Vitamin A refers to preformed
retinol and the carotenoids that are converted to retinol.
Preformed vitamin A is found only in animal products,
including organ meats, fish, egg yolks, and fortified milk.
More than 1500 synthetic retinoids, analogs of vitamin A,
have been developed. The current RDI for vitamin A is
1500 micrograms/L (5000 IU).
Vitamin C
Vitamin C (ascorbic acid) is a water-soluble vitamin widely
found in citrus fruits and raw leafy vegetables, citrus fruits,
strawberries, melons, tomatoes, broccoli, and peppers.
Humans cannot synthesize vitamin C and deficiency results
in scurvy.
Vitamin E
Vitamin E occurs in eight natural forms as tocopherols
(alpha, beta, gamma, and delta) and tocotrienols (alpha, beta,
gamma, and delta), all of which possess potent antioxidant
properties. Gammatocopherol is the predominant form of
vitamin E in the human diet, yet most studies have focused
on alphatocopherol, which is the type found in most over-
the-counter supplements. One reason for this is that
alphatocopherol is biologically more active than
gammatocopherol. Vitamin E deficiency is rare and is seen
primarily in special situations resulting in fat malabsorption,
including cystic fibrosis, chronic cholestatic liver disease,
abetalipoproteinemia, and short bowel syndrome.
Other essential vitamins
Vitamin B12
Vitamin B12 deficiency occurs in 5%–20% of older persons
(Andres et al 2004), but it is often unrecognized because
the clinical manifestations are subtle (Thomas 2004). Causes
of the deficiency include malabsorption of the vitamin (60%
of all cases), pernicious anemia (15%–20% of all cases),
and insufficient dietary intake. Measurement of vitamin B12
and folate concentrations will determine anemia due to these
causes in the majority of cases. Confirmation of vitamin
B12 deficiency in those patients who have values in the lower
normal range should be obtained, since about 50% of
patients with subclinical disease may have normal B12
levels. A more sensitive method of screening for vitamin
B12 deficiency is measurement of serum methylmalonic
acid and homocysteine levels, which are increased early in
vitamin B12 deficiency. A homocysteine level will be
elevated in both vitamin B12 and folate deficiencies, but a
methylmalonic acid level will be elevated only in vitamin
B12 deficiency. Renal failure is the only other confounding
cause of an elevated methylmalonic acid concentration.
Folic acid
Folate and vitamins B6 and B12 are required for the
conversion of homocysteine to methionine. Increases in
homocysteine have been associated with increased coronary
heart disease risk in observational trials. Inadequate folate
status is associated with neural tube defect in children
(Paulozzi et al 2001) and with colon cancer (Giovannucci
et al 1998). Folate occurs naturally in a variety of foods,
including liver; dark-green leafy vegetables such as collards,
turnip greens, and romaine lettuce; broccoli and asparagus;
citrus fruits and juices; whole grain products; wheat germ;
and dried beans and peas such as pinto, navy, and lima beans,
chickpeas and black-eyed peas. Effective from 1998, the
Food and Drug Agency required manufacturers to add from
0.43 mg–1.4 mg of folic acid per pound of product to
enriched flour, bread, rolls and buns, farina, corn grits,
cornmeal, rice, and noodle products.
Vitamin D
Vitamin D occurs naturally in animal foods as the provitamin
cholecalciferol. This requires conversion in the kidney to
the metabolically active form, calcitriol. Vitamin D is not a
true vitamin since humans are able to synthesize it with
adequate sunlight exposure. By photoconversion,
7-dehydrocholesterol becomes previtamin D3, which is
metabolized in the liver to the major circulating form of
vitamin D: 25-hydroxyvitamin D3. In the kidney, this is
converted to 2 metabolites, the more active one being
1,25-dihydroxyvitamin D3. Food sources include fortified
milk, saltwater fish, and fish-liver oil.
Thiamin
Thiamine pyrophosphate is a coenzyme for pyruvate
dehydrogenase, a-ketoglutarate dehydrogenase andClinical Interventions in Aging 2006:1(1) 84
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transketolase. Thiamine deficiency results in beriberi, a
syndrome that includes symptoms of weight loss, emotional
disturbances, impaired sensory perception, weakness, and
heart failure. Thiamine is found in fortified breads, cereals,
pasta, whole grains (especially wheat germ), lean meats
(especially pork), fish, dried beans, peas, and soybeans.
Dairy products, fruits, and vegetables are not very high in
thiamine, but when consumed in large amounts, they become
a significant source.
Pyridoxine
Vitamin B6 has been associated with cardiovascular risk
and lipids. Vitamin B6 is found in a wide variety of foods
including fortified cereals, beans, meat, poultry, fish, and
some fruits and vegetables.
Riboflavin
Deficiency is rare in the United States due to widely available
sources of this vitamin. Lean meats, eggs, legumes, nuts,
green leafy vegetables, dairy products, and milk provide
riboflavin in the diet. Breads and cereals are often fortified
with riboflavin. Other than deficiency states, association
with disease is unknown.
Minerals
Approximately 15 inorganic elements are required in minute
amounts. In humans, clinically symptomatic and reversible
deficiency disease has been established for iron, iodine,
copper, zinc, and selenium. Other elements, including
chromium, manganese, molybdenum, and vanadium, have
undoubted biological activity, but their relationship to
clinical practice is not as clear.
Evidence for association of vitamins and health
Evidence for the association of vitamins with health forms
three groups. At the first level, experimental observation
shows that a nutritional derangement in metabolic function
can be corrected in a person or animal by addition of a certain
organic compound back into the diet. This evidence basically
follows Koch’s postulates. Early experimental research
established the necessity of a number of vitamins,
demonstrated their metabolic effect, and identified their
sources in the diet. Diets defective in these organic
compounds produce a defined syndrome and are clearly
corrected when the vitamin is added back to the diet. Great
improvements in worldwide health followed this basic
nutritional discovery.
True vitamin deficiency states appear to be rare or
infrequently diagnosed in Western medicine. Most of these
deficiency states are associated with starvation. Clearly,
replacement of the specific vitamin associated with vitamin-
related disease results in a clinical cure. However, there is
concern that subclinical deficiencies of vitamins might be
associated with development of chronic disease even in the
absence of overt symptoms and signs. Diagnosing these
subclinical deficiencies has been problematic because it is
difficult to measure vitamin levels. Measurement of vitamin
levels usually requires high pressure liquid chromatography
and is very expensive in clinical practice. Some surrogate
markers are available, including retinol-binding protein,
methylmalonic acid, and homocysteine levels. All
measurements of vitamins are affected by the acute-phase
reaction of hepatic proteins and chronic inflammatory
disease.
The second level of evidence is epidemiological. By
examining the dietary history of a population and noting
the types of deranged metabolic functioning (disease), it
might be possible to identify the components of a “healthy
diet”, even when the diet might contain not-yet-recognized
compounds. These trials often use self-reported dietary
intake or measurement of vitamin levels, either taken at some
point prior to the development of a disease or after the
disease has manifested.
This epidemiological research is intriguing and
hypothesis-generating. However, epidemiological associa-
tion cannot prove causality. These epidemiological reports
produce a great deal of methodological problems. For
example, daily intake of green-yellow vegetables has been
associated with a 26% reduction in the risk of death from
all strokes in men and women when compared with intake
of once or less per week. Daily fruit intake has been
associated with a 35% reduction in risk of all strokes in
men and a 25% reduction in women. These data were based
on a cohort study of 40 349 Japanese adults followed from
1980–1998 (Sauvaget et al 2003). The data on dietary intake
was only recorded once in 1980. In other words, the amount
of fruit and vegetables reported at one point in time predicts
a decreased risk of stroke eighteen years later. We could
conclude that a self-reported daily intake of vegetables or
fruit may prevent stroke. It is also equally possible that
people who eat fruit and vegetables differ in some
unmeasured way from people who do not, and that this
confounds the association.
The third, and most rigorous level of evidence, is a
randomized, controlled clinical trial. The effect of aClinical Interventions in Aging 2006:1(1) 85
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hypothetical vital nutrient can then be directly observed over
time in a population.
Epidemiological associations
A large body of epidemiological evidence suggests that
eating a diet rich in sources of vitamins has a protective
effect on development of disease. If disease can be prevented
or delayed, longevity can be increased. Therefore, most
people believe that they can ward off many if not most
diseases and disability simply by knowing what foods to
eat, what supplements to consume, and what leisure
activities to pursue. This belief is encouraged by the
emphasis on preventive medicine. Millions of people now
eat low-fat, high-fiber diets, take antioxidant supplements,
drink alcohol only in moderation, stay slim, and exercise.
Table 1 summarizes examples of the epidemiological
associations of vitamins with specific disease states. The
epidemiological data suggest a clear association between
elevated homocysteine levels and higher risk of stroke and
cardiovascular disease. The risk of stroke is also higher for
persons who consume less fruits and vegetables. Folate
levels, which are dependent on homocysteine levels, are also
predictive of cardiovascular risk. Vitamin B6 has also been
associated with cardiovascular risk and lipids.
Taken together, the association between homocysteine
levels is strong. An association has been shown for carotid
disease (5 studies), coronary disease (2 studies), peripheral
vascular disease (1 study), and aortic atherosclerotic disease
(1 study). An increased risk of cardiovascular disease and
high levels of homocysteine levels has been shown in ten of
thirteen case-control studies and one cohort study. A
decreased risk for cardiovascular disease was also shown
with high levels of folate (3 of 5 prospective and 1 of 2
retrospective studies) and vitamin B6 (2 of 2 prospective
and 2 of 2 retrospective studies) but not with high levels of
vitamin B12 (1 prospective and 2 retrospective studies)
(Eikelboom et al 1999).
Other studies have not supported a link between
supplemental vitamins and disease. The self-reported intake
of vitamins E, C, or multivitamins was not associated with
decreased incidence of cardiovascular disease or cardio-
vascular mortality after adjusting for known cardiovascular
risk factors in a large observational study of male physicians
(Muntwyler et al 2002).
Lung function studies illustrate the sometimes confusing
data from epidemiological surveys. Forced expiratory
volume was associated with intake of vitamin E in Finland,
but only with dietary intake of fruit in Italy, and only with
betacarotene intake in the Netherlands. In all three countries,
men with above-average intakes of both fruit and vegetables
had a higher forced expiratory volume than those with a
low intake of both foods. After adjustment for energy intake,
the association of all three antioxidants disappeared (Tabak
et al 1999). Differences across populations, even over
relatively small distances, confound these studies.
Micronutrient intake, including lutein, zeaxanthin,
anhydrolutein, alphacryptoxanthin, betacryptoxanthin,
lycopene, dihydrolycopene, alphacarotene, betacarotene,
total carotenoids, retinol, alphatocopherol, betatocopherol,
gammatocopherol, deltatocopherol, and total tocopherols,
were examined in men who developed bladder cancer after
20 years of surveillance and compared with age-matched
controls. There were statistically significant inverse linear
trends in risk for alphacarotene, betacarotene, lutein plus
zeaxanthin, betacryptoxanthin, and total carotenoids.
However, after adjustment for pack-years of cigarette
smoking none of the inverse trends remained significant
(Nomura et al 2003).
Baseline intake of carotenes and vitamin C, or vitamin
E, in supplemental or dietary (nonsupplemental) form or in
both forms, was not related to a decreased risk of dementia
of the Alzheimer type after 4 years of follow-up (Luchsinger
et al 2003).
Not all observations demonstrate this effect. In one of
the largest epidemiological observations, 71 910 female
participants in the Nurses’ Health Study and 37 725 male
participants in the Health Professionals’ Follow-Up Study
who were free of major chronic disease were followed for
incidence of cardiovascular disease, cancer, or death. A
semiquantitative food-frequency questionnaire was obtained
in 1984, 1986, 1990, and 1994 for women and in 1986,
1990, and 1994 for men. The outcome was analyzed in 1998.
For men and women combined, persons who consumed the
highest quintile of total fruit and vegetables did not have a
lower risk for major chronic disease compared with those
in the lowest quintile of consumption. Total fruit and
vegetable intake was inversely associated with risk of
cardiovascular disease, but not with overall cancer incidence.
The benefits occurred in persons who had five or more daily
servings. Of the food groups analyzed, green leafy vegetable
intake showed the strongest inverse association with major
chronic disease and cardiovascular disease. For an increment
of one serving per day of green leafy vegetables, relative
risks were 0.95 (95% confidence intervals [CI] = 0.92–0.99)Clinical Interventions in Aging 2006:1(1) 86
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Table 1 Examples of epidemiological associations with diet, vitamins, or supplements with specific diseases
Study Population Condition Association Results 95% CI
Kittner et al 1999 167 women aged 15–44 First ischemic Plasma homocysteine Odds ratio 1.6 1.1–2.5
years vs 328 women stroke level ≥ 7.3 µmol/L
without a stroke
Cancer Prevention 26 593 male smokers, Cerebral Dietary intake of p-carotene Relative risk 0.61–0.99
Study 2000 – Hirvonen aged 50–69 years infarction 0.77
et al 2000
Cancer Prevention 26 593 male smokers, Cerebral Lycopene, lutein, zeaxanthin,  No association
Study 2002 – Hirvonen aged 50–69 years infarction Vitamin C, flavonols, flavones,
et al 2000 vitamin E
Robinson et al 1998  750 patients vs 800 controls Coronary Homocysteine concentrations Increased risk
artery disease > 80th percentile of control subjects
Robinson et al 1998 750 patients vs 800 controls Coronary Red cell folate < 10th percentile Increased risk
artery disease of controls
Robinson et al 1998 750 patients vs 800 controls Coronary Vitamin B6 < 20th percentile Increased risk
artery disease of controls
Anderson et al 2000  1412 patients  Coronary  Plasma total homocysteine levels Higher 3-year 15.7% vs 9.6%
artery disease mortality
Muntwyler et al 2002 83 639 male US physicians Cardiovascular Self-reported use of vitamins E, C, No association
with no history of disease or or multivitamins
cardiovascular disease cardiovascular
(CVD) or cancer mortality
Hung et al 2004 71 910 female participants in Incidence of Total fruit and vegetable intake by Relative risk for 0.89–1.01 for
the Nurses’ Health Study cardiovascular dietary questionnaire major chronic major chronic
and 37 725 male participants disease, cancer, disease of 0.95 for disease;
in the Health Professionals’ or death highest quintile vs 0.81–0.95 for
Follow-Up Study, free of lowest. Relative risk cardiovascular
chronic disease for greater than 5 disease;
servings daily 0.88 0. 95–1.05 for
for cardiovascular cancer
disease and 1.00
for cancer
Chen et al 2002  15 317 men and women Hypertension Lower levels of vitamin A and Higher risk of 43% vs 18%
> 20 years of age vitamin E hypertension
Chen et al 2002 15 317 men and women Hypertension Higher levels of alphacarotene and Lower risk of 16% vs 11%
> 20 years of age betacarotene hypertension
Chen et al 2002 15 317 men and women Hypertension Higher levels of vitamin C Lower diastolic
> 20 years of age pressure
Tabak et al 1999  Finland (n = 1248), Pulmonary Higher intake of fruits, vegetables Higher forced vital 53 mL–118 mL
Italy (n = 1386), and the capacity
Netherlands (n = 691)
middle-aged men
Tabak et al 1999 Finland (n = 1248), Pulmonary Higher intake of vitamin C, No association
Italy (n = 1386), and the betacarotene
Netherlands (n = 691)
middle-aged men
Tabak et al 1999 Finland (n = 1248), Pulmonary Higher intake of vitamin E No association
Italy (n = 1386), and the
Netherlands (n = 691)
middle-aged men
Nomura et al 2003  9345 Japanese-American men  Bladder cancer Alphacarotene, betacarotene, lutein No association after
plus zeaxanthin, betacryptoxanthin adjusting for smoking
and total carotenoids
Luchsinger et al 2003  980 elderly subjects free of Alzheimer Carotenes and vitamin C, or No association
dementia at baseline, disease vitamin E in supplemental or
followed for mean 4 years dietary (nonsupplemental) form
or in both formsClinical Interventions in Aging 2006:1(1) 87
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for major chronic disease and 0.89 (95% CI = 0.83–0.96)
for cardiovascular disease (Hung et al 2004). These findings
suggest that high consumption of fruits and vegetables
results in a small reduction in the risk of cardiovascular
disease. There was no association found between fruit and
vegetable intake (either total or of any particular group) and
overall cancer incidence.
Randomized controlled trials
Unfortunately, randomized controlled trials of specific
supplements have failed to demonstrate a consistent or
significant effect of any single vitamin or combination of
vitamins on incidence of or death from cardiovascular
disease (Morris and Carson 2003). Vitamin E plus vitamin
C plus betacarotene showed no difference in all-cause,
vascular, or nonvascular mortality, or secondary measures
including major coronary events, stroke, revascularization,
and cancer compared with placebo (Heart Protection Study
Collaborative Group 2002). In a meta-analysis of 135 967
participants in 19 randomized controlled trials using
vitamin E, nine of eleven trials showed an increased risk
for all-cause mortality at a dose greater than or equal to
400 IU per day of vitamin E. No increase in all-cause
mortality was seen for doses less than 400 IU per day in
these trials, but a dose-response analysis showed that a
statistically significant relationship between vitamin E
dosage and all-cause mortality began at a dose greater than
150 IU/day (Miller et al 2005). A similar increase in
mortality has been described in very high dose vitamin E
(2000 IU per day) supplementation in persons with
Alzheimer dementia (Sano et al 1997; Miller et al 2005).
Four placebo-controlled trials have not shown a benefit
of betacarotene, alone or combination with alphatocopherol
or retinol, or alphatocopherol alone on the development of
lung cancer. For people with risk factors for lung cancer, no
reduction in lung cancer incidence or mortality was found
in those taking vitamins alone compared with placebo. For
people with no known risk factors of lung cancer, none of
the vitamins or their combinations appeared to have any
effect. In fact, in combination with retinol, a statistically
significant increase in risk of lung cancer incidence was
found compared with placebo (Caraballoso et al 2003).
Table 2 summarizes examples of randomized controlled
trials and meta-analytical reviews for vitamins and specific
diseases. The data from randomized controlled trials show
(with a few exceptions) that supplementation with vitamins
has not had much effect on disease states. Vitamin D
supplementation, along with calcium, has been demonstrated
to reduce hip fracture rate in older persons. The use of
mineral and vitamin supplements has been shown to slow
the progression of, but not prevent, age-related macular
degeneration. Folate may have some role in the treatment
of depression, although the trials have been small in
numbers. Vitamin C may, or may not, have an effect on
hypertension, but the longest trials were only two months
in duration. Six controlled trials on supplementation of
vitamin C in persons with asthma showed no appreciable
benefit on asthma outcome (Ram et al 2003).
Trace elements, but not vitamins alone, have been shown
to produce higher antibody titers after influenza vaccination
in older persons, but had no effect on infection rate or
survival. In a meta-analysis of 8 trials of older persons, the
effect on multivitamin and mineral supplements on
infectious disease was examined. Multivitamins and mineral
supplements were found to reduce the mean annual number
of days spent with infection by 17.5 in three studies.
However, the odds ratio for having at least one infection in
the study period and the incidence rate for treated compared
with control subjects was not different (El-Kadiki and Sutton
2005).
Summary and clinical relevance
Evidence of epidemiological associations of vitamins and
disease states has been found for nine vitamins. Inadequate
folate status is associated with neural tube defect and some
cancers. Folate and vitamins B6 and B12 are required for
homocysteine metabolism and are associated with coronary
heart disease risk. Vitamin E and lycopene may decrease
the risk of prostate cancer. Vitamin D is associated with
decreased occurrence of fractures when taken with calcium
(Fairfield and Fletcher 2002). Zinc, betacarotene, and
vitamin E appear to slow the progression of macular
degeneration, but do not reduce the incidence.
In observational studies (case-control or cohort design),
people with high intake of antioxidant vitamins by regular
diet or as food supplements generally have a lower risk of
myocardial infarction and stroke than people who are low-
consumers of antioxidant vitamins. The association in
observation studies has been shown for carotene, ascorbic
acid, and tocopherol. The use of various dietary supplements,
including vitamins, to prevent or delay disease or aging rests
for the most part on epidemiological associations. It does
appear from this data that a diet rich in vitamins is associated
with a tendency to improved health.
However, the results from controlled trials are dismal.
In randomized controlled trials, antioxidant vitamins as foodClinical Interventions in Aging 2006:1(1) 88
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Table 2 Examples of controlled trials of vitamins or supplements on specific diseases
Study Population Condition Intervention Results Effect
Heart Protection 20 536 subjects Coronary heart Vitamin E 600 mg/d, plus All-cause, vascular, or No difference
Study Collaborative followed 5 years disease, vascular vitamin C 250 mg/d, nonvascular mortality, or
Group 2002 occlusive disease, plus betacarotene secondary measures
diabetes mellitus, 20 mg/d or placebo including major coronary
hypertension events, stroke,
revascularization, and cancer
The SU.VI.MAX 13 017 persons, Cancer, 120 mg ascorbic acid, Total cancer incidence 4.1% No difference; may have
Study 2004 – age 45–60, followed cardiovascular 30 mg of vitamin E, vs 4.5%; ischemic cardio- small protective effect in
Hercberg et al 2004 7.5 years disease or 6 mg of betacarotene, vascular disease incidence men
cardiovascular 100 µg of selenium, 2.1% vs 2.1%, all-cause
mortality 20 mg of zinc vs placebo mortality 1.2% vs 1.5%
HOPE and 3994 persons, Cardiovascular Vitamin E 400 IU/d Cancer incidence 11.6% vs  No difference. Higher risk
HOPE-TOO Trial > 55 years with CVD events and cancer vs placebo 12.3%; cancer deaths of congestive heart failure
2005 or cardiovascular 3.3% vs 3.7%; major (CHF) and hospitalization
disease; diabetes cardiovascular events for CHF
mellitus followed 21.5% vs 20.6%
7 years
Heart Protection   15 000 men aged Cardiovascular Daily combination of  Incidence No significant reduction
Study Collaborative 40–80, followed disease vitamin E (600 mg),
Group 2002 5 years vitamin C (250 mg), and
betacarotene (20 mg)
Meta-analysis 2005 135 967 participants All-cause mortality Vitamin E ≥ 400 IU/d 39 deaths per 10 000 Higher mortality
– Miller et al 2005 in 19 clinical trials persons (3–74 per 10 000
persons; p = 0.035)
Mullan et al 2002 30 patients, 45–70 Hypertension 500 mg of ascorbic acid Mean systolic 9.9 mmHg,  Reduced systolic blood
years old, with daily mean diastolic 6.0 mmHg pressure
type 2 diabetes,
followed 4 weeks
Kim et al 2002 439 subjects Hypertension 500 mg of vitamin C Blood pressure No reduction
followed 5 years daily
Pfeifer et al 2001 148 women, mean Hypertension 1200 mg calcium plus Decrease in systolic blood Improved
age 74 years 800 IU vitamin D3 or pressure of 9.3%
followed 8 weeks 1200 mg calcium/day
Ram et al 2003 Six trials Asthma Vitamin C Asthma outcome No difference
supplementation
Caraballoso et al 109 394 subjects Lung cancer Betacarotene, alone or Cancer incidence No reduction
2003 combination with alpha-
tocopherol or retinol, or
alphatocopherol alone
The Betacarotene 18 314 subjects, Lung cancer Betacarotene and 28% (4%–57%) higher Worse outcome
and Retinol Efficacy 45–74 years, at high retinyl palmitate cancer incidence and 17%
Trial 1996 – Omenn risk, followed compared with placebo (3%–33%) higher total
et al 1996 4 years mortality in the
supplemented group
Virtamo et al 2003  25 390 persons Prostate cancer Alphatocopherol  Relative risk 0.88 No difference
followed 6 years (0.76–1.03)
Virtamo et al 2003 25 390 persons Prostate cancer Betacarotene Relative risk 1.06 No difference
followed 6 years (0.91–1.23)
Greenberg et al 864 subjects Incidence of colon Placebo, betacarotene Relative risk 1.01 (0.85–1.20) No difference
1994 polyps (25 mg daily), vitamin C for betacarotene and 1.08
(1 g daily) and vitamin E (0.91 to 1.29) for vitamin C
(400 mg daily), or and E
betacarotene plus
vitamins C and E
Rodriguez-Martin 50 subjects, Alzheimer Thiamine Cognitive status No benefit
et al 2003 followed 1 year dementia supplementation
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Study Population Condition Intervention Results Effect
Alzheimer’s Disease 341 subjects Alzheimer Vitamin E 1000 mg  Time to either death, Reduced in vitamin E group
Cooperative Study followed 2 years dementia twice a day, selegiline institutionalization, decline in (670 days) and selegiline
1997 – Sano et al 5 mg twice a day, both activities of daily living, or group (655 days) compared
1997 or placebo progression to severe with placebo group (440
dementia days), higher mortality 1.08
(1.01–1.14)
Lerner et al 2002 15 subjects Schizophrenia Vitamin B6 400 mg vs Mental status No difference
placebo
Taylor et al 2003 247 subjects Depression Folic acid Reduction in depression 2.65 points, CI 0.38–4.93 
scores
Christen et al 2003  22 071 male US Cataract Betacarotene 50 mg on Incidence No benefit
physicians aged alternate days vs
40–84 years, placebo
followed 1 year
Evans 2003 4119 subjects in Age-related macular Antioxidant and zinc Risk ratio 0.72 (0.52–0.98) Less risk
7 trials degeneration, supplementation
progression to
advanced disease
Evans 2003 4119 subjects in Age-related macular Vitamin E, betacarotene Prevention No benefit
7 trials degeneration or both
Girodon et al 1999 725 institutionalized Antibody titers, Trace elements (zinc Antibody titers after Higher titers with minerals
elderly subjects respiratory and selenium sulfide) or influenza vaccine were higher but low with vitamins
> 65 years, followed infections, urinary vitamins (betacarotene, in groups that received trace
2 years tract infections, ascorbic acid, and elements alone or associated
survival rate vitamin E) or a placebo with vitamins, but the vitamin
group had significantly lower
antibody titers
Chandra 1992 96 subjects Infection-related Vitamin A 400 units, beta- 23 (23–28) vs 48 fewer Improved
illness, days taking carotene 16 mg; thiamine infection-related illness days; 
antibiotics, 2.2 mg; riboflavin 1.5 mg; 18 (12–16) vs 32 fewer days
nutritional niacin 16 mg; vitamin B6 taking antibiotics
deficiencies 3.0 mg; folate 400 µg;
vitamin B12 4.0 µg; vitamin
C 80 mg; vitamin D 4 µg;
vitamin E 44 mg; iron
16 mg; zinc 14 mg; copper
1.4 mg; selenium 20 µg;
iodine 0.2 mg; calcium
200 mg; and magnesium
100 mg vs placebo
(calcium, 200 mg, and
magnesium, 100 mg)
El-Kadiki et al 2005 8 trials in older Days with infection, Any combination of 14 (10–18) fewer days with Fewer days with infection,
adults at least one vitamin or mineral infection; at least one no difference in incident
infection, incident supplements infection 1.10 (0.81–1.50); infections
infections incident infections 0.89
(0.78–1.03)
Gillespie et al 2003 Frail elderly subjects Hip fracture and Vitamin D3 supplemen- Risk ratio 0.74 (0.60–0.91) Less risk
vertebral fracture tation along with calcium
incidence
Gillespie et al 2003 Frail elderly subjects Hip fracture and Vitamin D3 supplemen- Risk ratio 1.20 (0.83–1.75) No difference
vertebral fracture tation alone without
incidence calcium
Gillespie et al 2003 In healthy younger, Hip fracture Vitamin D3 supplemen- Risk ratio 0.36 (0.01–8.78) No difference
ambulatory subjects tation along with calcium
Gillespie et al 2003 In healthy younger, Nonvertebral Vitamin D3 supplemen- Risk ratio 0.46 (0.23–0.90) Less risk
ambulatory subjects fracture tation along with calciumClinical Interventions in Aging 2006:1(1) 90
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supplements have no beneficial effects in the primary
prevention of myocardial infarction and stroke. The apparent
beneficial results of a high intake of antioxidant vitamins
reported in observational studies have not been confirmed
in large randomized trials (Asplund 2002).
The discrepancy between different types of studies is
probably explained by the fact that dietary composition and
supplement use is a component of a cluster of healthy
behavior. An alternative hypothesis is that there are as yet
unknown essential organic compounds in certain foods.
Much of the enthusiasm for the use of vitamin or mineral
supplements to prevent disease or increase longevity results
from the belief that supplementation is harmless. However,
serious adverse events have been reported. Toxicity may
result from excessive doses of vitamin A during early
pregnancy and from other fat-soluble vitamins taken in high
doses. There is increasing concern from randomized,
controlled trials that betacarotene and vitamin E may be
associated with a higher mortality risk.
The most prudent approach is to recommend a daily
intake of fruits and vegetables as a likely source of essential
nutrients. Failing compliance with a natural source of
essential nutrients, and in populations at high risk of vitamin
deficiency, vitamin supplements should be encouraged.
Vitamin supplements should be used as replacement doses
guided by RDI and supertherapeutic doses should be
avoided.
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